中国继续医学教育
中國繼續醫學教育
중국계속의학교육
CHINA CONTINUING MEDICAL EDUCATION
2015年
16期
101-101
,共1页
支气管扩张%支气管哮喘%临床疗效
支氣管擴張%支氣管哮喘%臨床療效
지기관확장%지기관효천%림상료효
Bronchiectasis%Bronchial asthma%Clinical curative effect
目的：探讨支气管扩张合并支气管哮喘的临床疗效。方法回顾性分析2014年11月～2015年2月于我院就诊的100例支气管扩张合并支气管哮喘患者，将其随机分为试验组和对照组，每组50例。对照组采用西医普通治疗，实验组在对照组治疗基础上加服激素类药物，分析两组患者实验结果。结果实验组总有效率为94%，对照组总有效率为80%，两组比较，实验组总有效率高于对照组，P＜0.05，差异有统计学意义。结论激素吸入是治疗支气管扩张合并支气管哮喘的首选药之一，其疗效显著，不良反应少，副作用低，对支气管患者伤害小。
目的：探討支氣管擴張閤併支氣管哮喘的臨床療效。方法迴顧性分析2014年11月～2015年2月于我院就診的100例支氣管擴張閤併支氣管哮喘患者，將其隨機分為試驗組和對照組，每組50例。對照組採用西醫普通治療，實驗組在對照組治療基礎上加服激素類藥物，分析兩組患者實驗結果。結果實驗組總有效率為94%，對照組總有效率為80%，兩組比較，實驗組總有效率高于對照組，P＜0.05，差異有統計學意義。結論激素吸入是治療支氣管擴張閤併支氣管哮喘的首選藥之一，其療效顯著，不良反應少，副作用低，對支氣管患者傷害小。
목적：탐토지기관확장합병지기관효천적림상료효。방법회고성분석2014년11월～2015년2월우아원취진적100례지기관확장합병지기관효천환자，장기수궤분위시험조화대조조，매조50례。대조조채용서의보통치료，실험조재대조조치료기출상가복격소류약물，분석량조환자실험결과。결과실험조총유효솔위94%，대조조총유효솔위80%，량조비교，실험조총유효솔고우대조조，P＜0.05，차이유통계학의의。결론격소흡입시치료지기관확장합병지기관효천적수선약지일，기료효현저，불량반응소，부작용저，대지기관환자상해소。
Objective To explore the clinical effect on bronchiectasis combine with bronchial asthma. Methods Retrospective analyzed of 100 cases with dilated bronchial asthma from November 2014 to February 2015 in our hospital, divided into experimental group and control group randomly, 50 cases in control group, using western medicine general treatment, each group had 50 cases. The control group adopts western medicine and the experimental group on the basis of control group treatment with hormone drugs, analyzed two group’s experimental groups the results. Results The experimental group total effective rate was 94%, the control group total effective rate was 80%, compared the two groups, the total effective rate of experimental group was higher than the control group, P<0.05, had difference statistically signiifcance. Conclusion Glucocorticoid inhalation is one of the drug of choice for treatment of bronchiectasis with bronchial asthma, the curative effect, less adverse reaction, low side effects, patients of bronchial damage is small.
